Business
AstraZeneca COVID-19 vaccine faces regulatory hurdles as Novavax releases both ‘encouraging’ and ‘concerning’ results – ABC News
European regulatory bodies are questioning the lack of data supplied for the Oxford-AstraZeneca vaccine, recommending against its use for the elderly, as another…
Experts say the problems associated with “first-generation” COVID-19 vaccines are being exposed, as one European regulatory body questions the lack of data supplied for the Oxford-AstraZeneca vaccine and recommends against its use for the elderly.
Key points:
- European regulatory bodies are concerned over the lack of data for the elderly during trials of the Oxford-AstraZeneca vaccine
- The TGA, described as “the best regulator in the world” by the Health Minister, is expected to make a decision in…
Continue Reading
-
Noosa News16 hours agoForum responds to urgent homelessness issues in Nambour
-
Noosa News15 hours agoQueensland weather forecast sees sunny weather for last week of winter
-
Business14 hours agoDoes Macquarie rate BHP shares a buy after its FY25 results?
-
General18 hours agoFirst home buyers score early access to deposit scheme